Increased matrix metalloproteinases 2 and 9 and tissue inhibitor of matrix metalloproteinase 2 expression is associated with progression from vulvar intraepithelial neoplasia to invasive carcinoma
Authors:
Open Access
- 1 March 2010
- journal article
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 89 (3) , 380-384
Abstract
Objective. The expression of matrix metalloproteinases 2 (MMP‐2) and 9 (MMP‐9) and tissue inhibitors of matrix metalloproteinases 1 (TIMP‐1) and 2 (TIMP‐2) in vulvar intraepithelial neoplasia (VIN I–III) and in vulvar invasive carcinoma were evaluated. Design. A retrospective study. Setting. Oulu University Hospital, Finland. Sample. The study population consisted of 68 patients with vulvar neoplasia (13 VIN I, 5 VIN II, 6 VIN III and 44 squamous cell carcinomas). Methods. Paraffin‐embedded tissue samples were examined by immunohistochemistry. Main outcome measures. MMP‐2, MMP‐9, TIMP‐1 and TIMP‐2 expression in VIN compared to vulvar carcinoma. Results. In VIN I–III MMP‐2 expression was positive in 13%, MMP‐9 in 13%, TIMP‐1 in 50% and TIMP‐2 in 17% of patients. The positive expressions in patients with vulvar carcinoma were 52% for MMP‐2, 36% for MMP‐9, 41% for TIMP‐1 and 78% for TIMP‐2. Conclusions. We conclude that over‐expression of MMP‐2, MMP‐9 and TIMP‐2 may be associated with the progression from VIN to invasive vulvar squamous cell carcinoma.Keywords
This publication has 22 references indexed in Scilit:
- Immunoexpression and prognostic significance of TIMP-1 and -2 in oral squamous cell carcinomaOral Oncology, 2005
- Gelatinases A and B (MMP-2 and MMP-9) in endometrial cancer—MMP-9 correlates to the grade and the stageGynecologic Oncology, 2004
- Comparative study of MMP-2 (matrix metalloproteinase 2) immune expression in normal uterine cervix, intraepithelial neoplasias, and squamous cells cervical carcinomaAmerican Journal of Obstetrics and Gynecology, 2004
- A comparative study of MMP-2 in vulvar neoplasmsGynecologic Oncology, 2004
- Changes in matrix metalloproteinases and their endogenous inhibitors during tumor progression in the uterine cervixJournal of Cancer Research and Clinical Oncology, 2003
- MMP-1 and MMP-2 in the Cervix Uteri in Different Steps of Malignant Transformation—An Immunohistochemical StudyGynecologic Oncology, 2002
- Prognostic Significance of Epithelial Disorders Adjacent to Invasive Vulvar CarcinomasGynecologic Oncology, 2001
- Matrix Metalloproteinase 2 Immunoreactive Protein Appears Early in Cervical Epithelial DedifferentiationGynecologic Oncology, 1999
- Expression of Matrix Metalloproteinase-9 in Squamous Cell Carcinoma of the Uterine Cervix—Clinicopathologic Study Using Immunohistochemistry and mRNAin SituHybridizationGynecologic Oncology, 1999
- Immunohistochemical localization of matrix metallloproteinase 2 and its specific inhibitor timp‐2 in neoplastic tissues with monclonal antibodiesInternational Journal of Cancer, 1994